文献速递神经肿瘤神经重症

抗癫痫药物持续时间对幕上高级别胶质瘤切除术后癫痫的影响

Impact of anti-seizure medication duration on postoperative seizures following supratentorial high-grade glioma resection: a mixed-model and tree-based approach.
PubMed 文献 · J Neurooncol · 2025-12-23

该回顾性队列研究纳入206例成人高级别胶质瘤切除患者,分析抗癫痫药物(ASM)持续时间与术后癫痫的关系。样条回归未发现显著关联,但决策树提示年龄>52.5岁且次全切除者ASM≤135天时癫痫风险增高,延长用药可能降低该亚组风险。

要点

  • ASM持续时间与术后癫痫总体无显著关联。
  • 年龄>52.5岁且次全切除者ASM≤135天时风险增高。
  • 该高危亚组延长ASM可能降低癫痫发生率。

核心结论

  • 延长ASM预防未广泛降低癫痫风险,但决策树提示老年次全切除亚组可能获益。

研究设计与样本

  • 回顾性队列研究,纳入206例成人高级别胶质瘤切除患者,主要结局为术后癫痫发生。

主要发现

  • 样条回归显示ASM持续时间与癫痫发生无统计学显著关联(pseudo R²=0.0066;p=0.69)。
  • 决策树提示年龄>52.5岁且次全切除者ASM≤135天时癫痫风险增高。

关键数值与推荐

  • 年龄>52.5岁且次全切除者ASM≤135天为高风险亚组。

临床怎么用

  • 对年龄>52.5岁且次全切除的高级别胶质瘤患者,可考虑延长ASM超过135天以降低癫痫风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Postoperative seizures are a significant complication following glioma surgery. While prophylactic antiseizure medications (ASMs) are widely prescribed, the optimal duration of prophylaxis remains unclear. Current guidelines lack specificity regarding high-risk subgroups that may benefit from extended ASM therapy. Here, we aimed to determine whether ASM duration affects postoperative seizure occurrence and to identify patient subgroups in whom longer ASM prophylaxis significantly reduces seizure risk. METHODS: We conducted a retrospective cohort study of 206 adult high-grade glioma patients who underwent resection. Postoperative seizure occurrence was the primary outcome. ASM duration was modeled using logistic regression with cubic splines to detect non-linear effects, and a classification decision tree was trained to identify high-risk subgroups. Observed seizure rates were compared across data-driven ASM duration thresholds. Time-to-event analysis was also performed. RESULTS: Mean age was 48.1 years (SD 15.9); 48.5% were male. Most tumors were located in the frontal (43.3%) and temporal lobes (29.6%), with glioblastoma being the most common histology (65%). Spline regression revealed no statistically significant association between ASM duration and seizure occurrence (pseudo R² = 0.0066; p = 0.69). However, decision tree analysis suggested a clinically meaningful subgroup: patients aged > 52.5 years with subtotal resection had increased seizure risk when ASM duration was ≤ 135 days. In this group, extending ASM prophylaxis was associated with a lower seizure rate. CONCLUSION: While extended ASM prophylaxis was not broadly associated with reduced seizure risk, tree-based analysis suggested an older, incompletely resected subgroup that may benefit from prolonged ASM use. REGISTRATION NUMBER: IR.TUMS.SINAHOSPITAL.REC.1402.091 retrospectively registered.

来源:J Neurooncol,查看原文。版权归原作者所有。

引用

  1. Amirkhani N, Maroufi F, Pour-Rashidi A, et al. Impact of anti-seizure medication duration on postoperative seizures following supratentorial high-grade glioma resection: a mixed-model and tree-based approach. J Neurooncol. 2025. PMID: 41432958. doi:10.1007/s11060-025-05373-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。